Literature DB >> 21917912

Reproductive empowerment: the main motivator and outcome of carrier testing.

Celine Lewis1, Heather Skirton, Ray Jones.   

Abstract

The aim of this Grounded Theory study was to assess the motivation and outcomes of carrier testing. Qualitative semi-structured interviews were conducted with participants who had undergone carrier testing for autosomal recessive, X-linked conditions and chromosome translocations. Reproductive empowerment emerged as the central phenomenon. A desire to manage risk was the main motivator for carrier testing, and information gathering the main facilitator. Participants were then able to make informed decisions, regain control over their reproductive risk and pass on information to family members. These findings support a patient-reported outcome measure of empowerment currently being developed for genetic services.

Entities:  

Mesh:

Year:  2011        PMID: 21917912     DOI: 10.1177/1359105311417193

Source DB:  PubMed          Journal:  J Health Psychol        ISSN: 1359-1053


  9 in total

1.  Expanded carrier screening panels-does bigger mean better?

Authors:  Sara Wienke; Kimberly Brown; Meagan Farmer; Charlie Strange
Journal:  J Community Genet       Date:  2013-09-24

2.  The decision-making process, experience, and perceptions of preimplantation genetic testing (PGT) users.

Authors:  Shachar Zuckerman; Sigal Gooldin; David A Zeevi; Gheona Altarescu
Journal:  J Assist Reprod Genet       Date:  2020-05-27       Impact factor: 3.412

3.  Experiences of Being Heterozygous for Fabry Disease: a Qualitative Study.

Authors:  Charlotte von der Lippe; Jan C Frich; Anna Harris; Kari Nyheim Solbrække
Journal:  J Genet Couns       Date:  2016-03-07       Impact factor: 2.537

4.  Understanding the impact of genetic testing for inherited retinal dystrophy.

Authors:  Ryan Combs; Marion McAllister; Katherine Payne; Jo Lowndes; Sophie Devery; Andrew R Webster; Susan M Downes; Anthony T Moore; Simon Ramsden; Graeme Black; Georgina Hall
Journal:  Eur J Hum Genet       Date:  2013-02-13       Impact factor: 4.246

Review 5.  Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.

Authors:  Norita Hussein; Stephen F Weng; Joe Kai; Jos Kleijnen; Nadeem Qureshi
Journal:  Cochrane Database Syst Rev       Date:  2018-03-14

Review 6.  Incorporating patient perspectives in the development of a core outcome set for reproductive genetic carrier screening: a sequential systematic review.

Authors:  Ebony Richardson; Alison McEwen; Toby Newton-John; Ashley Crook; Chris Jacobs
Journal:  Eur J Hum Genet       Date:  2022-03-28       Impact factor: 5.351

7.  Experiences of Women Who Have Had Carrier Testing for Duchenne Muscular Dystrophy and Becker Muscular Dystrophy During Adolescence.

Authors:  Harry G Fraser; Rebecca Z Redmond; Diana F Scotcher
Journal:  J Genet Couns       Date:  2018-07-04       Impact factor: 2.537

8.  Outcomes of Importance to Patients in Reproductive Genetic Carrier Screening: A Qualitative Study to Inform a Core Outcome Set.

Authors:  Ebony Richardson; Alison McEwen; Toby Newton-John; Ashley Crook; Chris Jacobs
Journal:  J Pers Med       Date:  2022-08-12

9.  The Process of Disclosure: Mothers' Experiences of Communicating X-Linked Carrier Risk Information to At-Risk Daughters.

Authors:  Amy Goldman; Alison Metcalfe; Rhona MacLeod
Journal:  J Genet Couns       Date:  2018-03-19       Impact factor: 2.537

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.